4.6 Article

Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease

期刊

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2015.10.140

关键词

Huntington's disease; Brain urea; Human brain; Metabolic brain disease; GC MS; Neurodegenerative disease

资金

  1. CHDI Foundation [A-8247]
  2. Endocore Research Trust [61047]
  3. Maurice and Phyllis Paykel Trust [3627036]
  4. Neurological Foundation of New Zealand
  5. Maurice Wilkins Centre for Molecular Biodiscovery
  6. Health Research Council of New Zealand [HRC 08-049]
  7. University of Auckland [JXU058 PReSS]
  8. Oakley Mental Health Research Trust [3627092]
  9. Medical Research Council (UK) [MR/L010445/1, MR/L011093/1]
  10. Alzheimer's Research UK [ARUK-PPG2014B-7]
  11. University of Manchester
  12. CMFT
  13. Northwest Regional Development Agency
  14. Manchester Biomedical Research Centre
  15. Greater Manchester Comprehensive Local Research Network
  16. Alzheimers Research UK [ARUK-PPG2014B-7] Funding Source: researchfish

向作者/读者索取更多资源

Huntington's disease (HD) is a neurodegenerative disorder wherein the aetiological defect is a mutation in the Huntington's gene (HTT), which alters the structure of the huntingtin protein through the lengthening of a polyglutamine tract and initiates a cascade that ultimately leads to dementia and premature death. However, neurodegeneration typically manifests in HD only in middle age, and processes linking the causative mutation to brain disease are poorly understood. Here, our objective was to elucidate further the processes that cause neurodegeneration in HD, by measuring levels of metabolites in brain regions known to undergo varying degrees of damage. We applied gas-chromatography/mass spectrometry-based metabolomics in a case-control study of eleven brain regions in short post-mortem-delay human tissue from nine well-characterized HD patients and nine controls. Unexpectedly, a single major abnormality was evident in all eleven brain regions studied across the forebrain, midbrain and hindbrain, namely marked elevation of urea, a metabolite formed in the urea cycle by arginase-mediated cleavage of arginine. Urea cycle activity localizes primarily in the liver, where it functions to incorporate protein-derived amine-nitrogen into urea for recycling or urinary excretion. It also occurs in other cell-types, but systemic over-production of urea is not known in HD. These findings are consistent with impaired local urea regulation in brain, by up-regulation of synthesis and/or defective clearance. We hypothesize that defective brain urea metabolism could play a substantive role in the pathogenesis of neurodegeneration, perhaps via defects in osmoregulation or nitrogen metabolism. Brain urea metabolism is therefore a target for generating novel monitoring/imaging strategies and/or therapeutic interventions aimed at ameliorating the impact of HD in patients. (C) 2015 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据